Confusion over Homeopathic Medicine for Swine Flu H1N1 Clarified by the American Association of Homeopathic Pharmacists (AAHP)
|
| Posted
:
Wed, 28 Oct 2009 19:50:23 GMT |
| Author
:
American Association of Homeopathic Pharmacists |
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
NEWTOWN SQUARE, Pa., Oct. 28 AAHP-SwineFlu-info
NEWTOWN SQUARE, Pa., Oct. 28 /PRNewswire/ -- Recent news articles regarding Swine Flu H1N1 have been widespread. The virulence of the strain among humans and its implications for pandemic disease in humans may lead to increased interest in homeopathic treatments for Swine Flu H1N1.
The American Association of Homeopathic Pharmacists (AAHP), representing the major manufacturers and distributors of homeopathic drugs, wishes to inform the public of its view of the sale of homeopathic medicines to prevent and/or treat Swine Flu H1N1.
There is no homeopathic literature, nor clinical trial, which adequately supports a homeopathic drug for use as PROPHYLAXIS (or for prevention) for Swine Flu H1N1. In addition, any product labeled for prophylaxis of flu is prescription in nature, according to U.S. Food and Drug Administration's drug labeling guidelines, and is an inappropriate use of any product sold over the counter (or as a non-prescription drug).
Homeopathic drugs have a long history of effectiveness in the reduction of SYMPTOMS for flu. Appropriate use of homeopathic medicines according to the principle of similars involves the matching of symptoms in the diseased state with those symptoms caused by a specific substance in its homeopathic drug proving. As such, homeopathic medicines are used principally for the treatment of presented symptoms and are less associated with the causative agent of those symptoms. Thus, of importance are the symptoms manifested in the individual as a result of the "flu" rather than the agent that caused the symptoms. Literature supports the use of several homeopathic medicines for relief of symptoms of fever, chills, cough, sore throat, headache, body aches and fatigue. Symptoms of diarrhea and vomiting may also be relieved using homeopathic medicines. Swine Flu H1N1 has been characterized by symptoms of mild onset, sometimes resulting in serious negative outcomes even under professional care.
Accordingly, the AAHP makes clear its position that marketers, including Web sites, selling homeopathic medicines as over-the-counter products for prophylaxis of infectious diseases, in general including Swine Flu H1N1, may be in violation of federal and state law.
When properly used by trained medical professionals, some homeopathic medicines have been shown to be useful against an epidemic disease. However, infectious diseases require medical intervention because an absolute confirmation of infection with a particular disease-causing organism requires laboratory testing. Infectious diseases may not be self-limiting and require medical diagnosis or monitoring. In light of the foregoing, it is inappropriate for a homeopathic drug product to be sold over the counter while being promoted in any way for PROPHYLAXIS of an infectious disease.
About the AAHP: Founded in 1923, the AAHP is a not-for-profit corporation of the State Commonwealth of Virginia, representing the interests of homeopathic manufacturers, distributors, and individual pharmacists in cooperative efforts with regulatory agencies and other organizations nationally. The AAHP functions as a trade association within the homeopathic pharmaceutical industry to represent the opinions and interests of homeopathic product manufacturers and distributors, the FDA, other regulatory agencies and other trade associations. In addition, the association promotes high standards in manufacturing and distributing, communicates regulatory changes to member companies through a regular newsletter, and promotes professional communications, education, and research within the homeopathic community.
SOURCE American Association of Homeopathic Pharmacists
|
Copyright © 2008
PR Newswire. All rights reserved.
|
|
|
|
|
Related
News
Nashville's PAI Medical Group Hair Transplant Procedure Guarantee Update
PAI Medical Group of Tennessee is offering their patients a regrowth guarantee with every hair transplant procedure. This is a guarantee on results with less restrictions than ever before./I/P
P(PRWEB) November 26, 2009 -- For nearly 15 years, this world renowned hair transplant clinic ...
The Who to Perform February 7 During the Bridgestone Super Bowl XLIV Halftime Show on CBS
NEW YORK, Nov. 26 /PRNewswire/ -- THE WHO, one of the world's greatest and most dynamic rock and roll bands, will perform in the BRIDGESTONE SUPER BOWL XLIV HALFTIME SHOW on CBS Sports at Dolphin Stadium in South Florida on Sunday, February 7, the NFL announced today durin...
VRX Worldwide Announces Change of Auditor VANCOUVER, BRITISH COLUMBIA -- 11/26/09 --
VRX Worldwide Inc. (TSX VENTURE: VRW) announced today that Price Waterhouse Coopers LLP ("PWC") resigned as auditor of the Company and that Cinnamon Jang Willoughby & Co. ("CJW") has been appointed as ..
New Pacific Metals Corp. Announces Results for the Three Months Ended September 30, 2009 VANCOUVER, BRITISH COLUMBIA -- 11/26/09 --
New Pacific Metals Corp. (TSX VENTURE: NUX) (the "Company") announces its unaudited consolidated financial results for the three months ended September 30, 2009. All figures are expressed in Canadian dolla..
Diadem Announces Equity Financing to Raise Up to $750,000 MONTREAL, QUEBEC -- 11/26/09 --
Diadem Resources Ltd. (TSX VENTURE: DRL)("Diadem" or the "Company") announced today that it proposes to effect a non-brokered private placement of up to 15,000,000 Units at $0.05 per Unit to raise up to $750,000 of e..
World Food Funds Franchisor
Jorgan’s Foods, Inc. turned to World Food Association Organization to secure $12.6 million to refinance existing loans. The financing extinguishes 25 existing loan agreements before their scheduled maturity and is secured by existing real estate and business value. /I/P
PScottsdal...
Dianor Announces Closing of Private Placement VAL-D'OR, QUEBEC -- 11/26/09 --
Dianor Resources Inc. (TSX VENTURE: DOR) announces that it has completed a private placement by issuing an aggregate of 8,292,138 "flow-through" units to accredited investors in Saskatchewan and Nova Scotia and to th..
|
|
|
|
|
|
|
|
|